Search Result "FLT3-ITD"
Sorafenib as a Salvage Therapy in FLT3-ITD Negative Relapse/ Refractory Acute Myeloid Leukemia
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 10 Year: 2018 Page: 1489-1494
Author(s): Nan Yang,Zhenyang Gu,Zhanxiang Liu,Wenrong Huang,Shuhong Wang,Lili Wang,Chunji Gao
Scaffold-hopping of Linifanib to Design 6-phenylisoxazolo[3,4-b]pyridin-3-amineDerivatives as FLT3 Inhibitors for Treating Acute Myeloid Leukemia
Journal: Letters in Drug Design & Discovery
Volume: 21 Issue: 10 Year: 2024 Page: 1833-1846
Author(s):
Membrane Tyrosine Kinase Receptors Kit and FLT3 are an Important Targets for the Therapy of Acute Myeloid Leukemia
Journal: Current Cancer Therapy Reviews
Volume: 9 Issue: 3 Year: 2013 Page: 181-219
Author(s): Ugo Testa
Membrane Tyrosine Kinase Receptors are an Important Target for the Therapy of Acute Myeloid Leukemia
Journal: Current Cancer Therapy Reviews
Volume: 4 Issue: 1 Year: 2008 Page: 31-49
Author(s): Ugo Testa
Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 1867-1883
Author(s): Dirk Schmidt-Arras, Joachim Schwable, Frank- D. Bohmer, Hubert Serve
FLT3 and Acute Myelogenous Leukemia: Biology, Clinical Significance and Therapeutic Applications
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 2 Year: 2005 Page: 3449-3457
Author(s): A. S. Advani
Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16 Issue: 1 Year: 2016 Page: 128-135
Author(s): Krupa Shah,Sheefa Mirza,Urja Desai,Nayan Jain,Rakesh Rawal
Design of New Therapeutic Agents Targeting FLT3 Receptor Tyrosine Kinase Using Molecular Docking and 3D-QSAR Approach
Journal: Letters in Drug Design & Discovery
Volume: 17 Issue: 5 Year: 2020 Page: 585-596
Author(s): Swapnil Pandurang Bhujbal,Seketoulie Keretsu,Seung Joo Cho
State of the Art of the Therapeutic Perspective of Sorafenib Against Hematological Malignancies
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 28 Year: 2012 Page: 4875-4884
Author(s): G. Zauli,R. Voltan,V. Tisato,P. Secchiero
Inhibition of PI3K/mTOR Pathways with GDC-0980 in Pediatric Leukemia: Impact on Abnormal FLT-3 Activity and Cooperation with Intracellular Signaling Targets
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 1 Year: 2019 Page: 828-837
Author(s): Abdulhameed Al-Ghabkari,Maneka A. Perinpanayagam,Aru Narendran